Perspective
Published on 08 Jan 2024
Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1321318
- 6,289 views
- 14 citations
Type at least 3 characters
1,418 articles
Review
Published on 04 Jan 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1238517
- 2,898 views
Original Research
Published on 03 Jan 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1296948
- 2,736 views
- 3 citations
Original Research
Published on 22 Dec 2023
Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1239451
- 3,039 views
- 2 citations
Review
Published on 22 Dec 2023
Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301437
- 4,495 views
- 7 citations
Original Research
Published on 21 Dec 2023
Utilization of cancer immunotherapy in sub-Saharan Africa
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1266514
- 3,244 views
- 2 citations
Original Research
Published on 21 Dec 2023
Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1191611
- 2,102 views
Original Research
Published on 21 Dec 2023
Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1281650
- 2,731 views
- 3 citations
Review
Published on 20 Dec 2023
Review: therapeutic approaches for circadian modulation of the glioma microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1295030
- 3,364 views
- 2 citations
Case Report
Published on 15 Dec 2023
Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1329858
- 1,590 views
Original Research
Published on 13 Dec 2023
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1174999
- 1,934 views
- 2 citations
Correction
Published on 13 Dec 2023
Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1338060
- 895 views
Original Research
Published on 12 Dec 2023
Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1296814
- 1,488 views
Systematic Review
Published on 07 Dec 2023
Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1240318
- 5,089 views
- 5 citations
Original Research
Published on 07 Dec 2023
Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1285117
- 2,697 views
- 1 citation
Review
Published on 06 Dec 2023
Immunogenic chemotherapy: great potential for improving response rates
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1308681
- 2,597 views
- 10 citations